erythropoietin therapy

出典: meddic

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.


  • Darbepoetin enhances endothelium-dependent vasomotor function in patients with stable coronary artery disease only after preceding ischaemia/reperfusion.
  • Tilling L, Hunt J, Donald A, Clapp B, Chowienczyk P.SourceBritish Heart Foundation Centre, Cardiovascular Division, Department of Clinical Pharmacology, King's College London, St Thomas' Hospital, London SE1 7EH, UK.
  • Clinical science (London, England : 1979).Clin Sci (Lond).2012 Apr;122(7):329-36.
  • Vasoprotective effects of erythropoietin in animal models are mediated by endothelium-derived NO and/or mobilization of EPCs (endothelial progenitor cells) and may be enhanced by ischaemia: whether they are present in humans is unknown. We examined whether the erythropoietin analogue darbepoetin imp
  • PMID 21966999
  • Erythropoietin promotes the growth of pituitary adenomas by enhancing angiogenesis.
  • Yang J, Xiao Z, Li T, Gu X, Fan B.SourceDepartment of Neurosurgery, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, PR China.
  • International journal of oncology.Int J Oncol.2012 Apr;40(4):1230-7. doi: 10.3892/ijo.2011.1261. Epub 2011 Nov 11.
  • rhEPO is frequently used in clinical practice to treat anemia. However, recently rhEPO has been reported to accelerate tumor growth, progression and metastasis. Many pituitary adenoma patients, particularly those with macroprolactinomas, tend to have anemia and ma
  • PMID 22086127


  • 遺伝子組み換えヒトエリスロポエチン(rHuEPO)使用レジメン変更前後におけるヘモグロビン(Hb)変動の比較検討
  • 今田 直樹,奥原 紀子,大西 彰,平山 きふ,関 英夫,小山 正樹,北村 亮治,青木 正
  • 日本透析医学会雑誌 = Journal of Japanese Society for Dialysis Therapy
  • 近年赤血球造血刺激因子(erythropoiesis stimulating agent:ESA)製剤投与中の血液透析患者におけるhemoglobin cycling(Hb cycling)という概念が注目されている.これはESA投与中の血液透析患者にみられる非生理的なヘモグロビン(Hb)値の周期的な変動であり,Hb値の変動が大きいほど入院,合併症,死亡のリスクが高く,血液透析患者の予後を悪化させ …
  • NAID 10029406030
  • 赤血球osmotic fragilityに対する血液透析の影響に関する検討
  • 大河原 晋,鈴木 昌幸,深瀬 幸子,田部井 薫
  • 日本透析医学会雑誌 44(8), 675-680, 2011
  • … 血液透析(HD)症例を含めた慢性腎不全症例に認められる腎性貧血は相対的なerythropoietin産生低下とともに,赤血球脆弱性の関与も考えられているが,赤血球脆弱性に対するHDの影響に関する検討はいくつかの報告を認めるのみである.今回,維持HD症例12例を対象に,HD前後およびHD開始1時間後のdialyzer前後において,赤血球浸透圧脆弱性試験(osmotic fragility test)を施行し,赤血球osmotic fragilityに対するHDの影響,さらに …
  • NAID 130001014111


Abstract Symptomatic anemia is a common complication of chronic renal failure. Treatment is now possible with the availability of recombinant human erythropoietin (epoetin alfa). Previous experimental studies have suggested that ...
... developing DID. In this study, the investigators wish to explore the neuroprotective and angiogenic effects of systemic erythropoietin (EPO) therapy on vasospasm and autoregulation following SAH, and examine whether any ...


Erythropoietin: back to basics in iron or erythropoietin therapyFig.2: Erythropoietin therapy monitoring Vector 2




  • n.
carecurecuringpracticepsychotherapyregimenremediationremedytherapeutictreattreatmenttreatment protocol

WordNet   license wordnet

「(medicine) the act of caring for someone (as by medication or remedial training etc.); "the quarterback is undergoing treatment for a knee injury"; "he tried every treatment the doctors suggested"; "heat therapy gave the best relief"」

PrepTutorEJDIC   license prepejdic

「(病気の)治療,療法 / =psychotherapy」


  [★] エリスロポエチン

WordNet   license wordnet

「a glycoprotein secreted by the kidneys that stimulates the production of red blood cells」